Synlogic Inc (SYBX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.62
• Market Cap: $7.25M
• EPS: $-0.26
• 52-Week High: $1.96
• 52-Week Low: $0.54

About Synlogic Inc

Synlogic, Inc. is an innovative clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing synthetic biotic drugs aimed at transforming the treatment landscape for cancer, inflammatory, and metabolic diseases. With a proprietary platform that harnesses the power of engineered probiotics, Synlogic's pipeline includes several novel therapeutic candidates designed to provide targeted treatment solutions with enhanced efficacy and safety profiles. ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Synlogic Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SYBX pay dividends?

Synlogic Inc (SYBX) does not currently pay a regular dividend.

What is SYBX's market cap?

Synlogic Inc (SYBX) has a market capitalization of $7.25M with a current stock price of $0.62.